INTEGRA THERAPY LTD

Company Registration Number:
15855813 (England and Wales)

Unaudited statutory accounts for the year ended 31 July 2025

Period of accounts

Start date: 24 July 2024

End date: 31 July 2025

INTEGRA THERAPY LTD

Contents of the Financial Statements

for the Period Ended 31 July 2025

Company Information - 3
Profit and Loss Account - 4
Balance sheet - 5
Additional notes - 7
Balance sheet notes - 10

INTEGRA THERAPY LTD

Company Information

for the Period Ended 31 July 2025




Director: Anna Nagorska
Registered office: 38
Broadhurst Avenue
St. Helens
England
WA9 5XX
Company Registration Number: 15855813 (England and Wales)

INTEGRA THERAPY LTD

Profit and Loss Account

for the Period Ended 31 July 2025


Notes

2025
£
Turnover 25,710
Gross Profit or (Loss) 25,710
Administrative Expenses ( 7,970 )
Operating Profit or (Loss) 17,740
Profit or (Loss) Before Tax 17,740
Profit or (Loss) for Period 17,740

The notes form part of these financial statements

INTEGRA THERAPY LTD

Balance sheet

As at 31 July 2025


Notes

2025
£
Fixed assets
Tangible assets: 4 1,500
Total fixed assets: 1,500
Current assets
Cash at bank and in hand: 900
Total current assets: 900
Net current assets (liabilities): 900
Total assets less current liabilities: 2,400
Total net assets (liabilities): 2,400

The notes form part of these financial statements

INTEGRA THERAPY LTD

Balance sheet continued

As at 31 July 2025


Notes

2025
£
Capital and reserves
Called up share capital: 2,400
Shareholders funds: 2,400

For the year ending 31 July 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 28 September 2025
And Signed On Behalf Of The Board By:

Name: Anna Nagorska
Status: Director

The notes form part of these financial statements

INTEGRA THERAPY LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

INTEGRA THERAPY LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

  • 2. Employees


    2025
    Average number of employees during the period 0

INTEGRA THERAPY LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

  • 3. Off balance sheet disclosure

    No

INTEGRA THERAPY LTD

Notes to the Financial Statements

for the Period Ended 31 July 2025

4. Tangible assets

Office equipment Total
Cost £ £
Additions 1,500 1,500
Disposals - -
Revaluations - -
Transfers - -
At 31 July 2025 1,500 1,500
Depreciation
Charge for year - -
On disposals - -
Other adjustments - -
At 31 July 2025 - -
Net book value
At 31 July 2025 1,500 1,500